Hikma Pharmaceuticals Plc (OP: HKMPY )
69.50 USD -3.51 (-4.81%) Official Closing Price Updated: 2:41 PM EST, Jan 26, 2021 Add to My Watchlist
All news about Hikma Pharmaceuticals Plc
Hikma's commitment to environmental performance recognised with "A-" rating in 2020 CDP Global Climate Change Report
January 13, 2021
Hikma launches generic Advair Diskus® following FDA approval
December 17, 2020
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces it has received FDA approval for and launched its generic version of GlaxoSmithKline's Advair Diskus®1...
Sesen Bio Announces Partnership with Hikma Pharmaceuticals for the Commercialization of Vicineum™ in the Middle East and North Africa
December 01, 2020
Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, and Hikma Pharmaceuticals, a multi-national...
Hikma and Arecor expand collaboration with new agreement to develop and commercialise ready-to-administer medicine
October 20, 2020
Hikma receives favourable court ruling for its generic Vascepa®
September 03, 2020
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces that the US Court of Appeals for the Federal Circuit today upheld a ruling by the US District Court for the...
Hikma Ventures Participates in CAD4.0 million Series A Financing Round for SeamlessMD to Expand Digital Patient Engagement Leadership
August 26, 2020
Hikma Pharmaceuticals PLC (Hikma) announces that its venture capital arm, Hikma Ventures has participated in a CAD4.0 million Series A round of financing for SeamlessMD. The round was led by MEDTEQ,...
Twitter Looks At Crashing Microsoft’s TikTok Party
August 10, 2020
Over the weekend it was reported that social media firm Twitter has held initial talks about a possible deal to acquire TikTok’s US operation, something that Microsoft has spent weeks negotiating with...
From Blogs - TalkMarkets
Hikma receives FDA approval for its generic Vascepa®
May 22, 2020
Hikma Pharmaceuticals PLC (Hikma), the multinational generic pharmaceutical company, today announces that its wholly owned U.S. subsidiary Hikma Pharmaceuticals USA Inc. has received approval from the...
Hikma launches employee matching donation campaign to support local US food banks and pantries
May 11, 2020
Campaign will help address significant increase in demand caused by COVID-19 related job losses and furloughs
Hikma Ventures invests in Altoida, Inc., a predictive digital biomarker company using AI and AR to help predict brain diseases with up to 94% accuracy
May 04, 2020
Hikma Pharmaceuticals PLC announces that its venture capital arm, Hikma Ventures has invested in Altoida, Inc. following the company's $6.3 million Series A round in 2019.
Altoida Inc. Secures Investment from Hikma Ventures to Drive Better Clinical Outcomes for Brain Diseases
May 04, 2020
Altoida's FDA-cleared and CE Mark-approved medical device and brain health data platform detects Alzheimer's Disease (AD) up to ten years prior to onset - with up to 94% accuracy
Why Did Amarin's Stock Fall Off a Cliff?
April 02, 2020
The shares of Amarin Corporation plc (NASDAQ: AMRN) tanked in the after-hours session on Monday as thecourt ruled against its ...
Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, today confirms that the United States District Court for the District of Nevada has ruled that Hikma's...
Hikma and Glenmark Pharmaceuticals Enter into Exclusive Licensing Agreement for Commercialising Ryaltris™ Seasonal Allergic Rhinitis Nasal Spray in the US
February 27, 2020
Arecor and Hikma Announce Exclusive Agreement to Develop and Commercialise Ready-To-Use Medicine Using Arestat™ Technology
January 09, 2020
Hikma and Arecor announce exclusive agreement to develop and commercialise ready-to-use medicine using Arestat™ technology
January 09, 2020
Up 25% in 2 Months, This Healthcare Stock Could Climb Even Higher
December 18, 2019
Here is why Jazz Pharmaceuticals could survive the threat from generics for its top-selling product.
Stocks That Hit 52-Week Highs On Tuesday
December 10, 2019
During Tuesday, 224 stocks hit new 52-week highs. Noteables: The largest company by market cap to hit a new 52-week high was ...
Civica Rx and Hikma Announce Shipments of Heparin and Seven Other Essential Injectable Medicines
December 10, 2019
Civica Rx (Civica, Inc.) and Hikma Pharmaceuticals PLC (Hikma, Group) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY) (rated Ba1/stable Moody's and BB+/positive S&P), the multinational generic...
Hikma Ventures leads Series A financing for development of Winterlight Labs' AI vocal technology to detect central nervous system disorders and track efficacy of treatments
November 18, 2019
Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), (rated Ba1 Moody's / BB+ S&P, both stable) announces that its venture capital arm, Hikma Ventures has led a CAD 5.6 million...
Hikma launches prefilled syringes in the US
September 17, 2019
Heparin Sodium Injection in a ready-to-use syringe is the first product using Hikma's new injectable manufacturing capability
Hikma and Civica Rx sign long-term agreement to reduce generic drug shortages in the US
July 23, 2019
Hikma Pharmaceuticals PLC (Hikma) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), (rated Ba1 Moody's / BB+ S&P, both stable) today announced its venture capital arm Hikma Ventures has participated in an...
Pillo Health Raises $11M in Series-A Funding from Stanley Black & Decker and Samsung Ventures to Fuel Development of Voice-First Healthcare Platform for the Home
May 29, 2019
Pillo Health, a Boston-based technology company improving longevity and quality of life for patients managing their health at home, today announced that is has secured $11 million in funding from...